[go: up one dir, main page]

NO20034778D0 - Farmasöytiske sammensetninger for oral og topisk anvendelse - Google Patents

Farmasöytiske sammensetninger for oral og topisk anvendelse

Info

Publication number
NO20034778D0
NO20034778D0 NO20034778A NO20034778A NO20034778D0 NO 20034778 D0 NO20034778 D0 NO 20034778D0 NO 20034778 A NO20034778 A NO 20034778A NO 20034778 A NO20034778 A NO 20034778A NO 20034778 D0 NO20034778 D0 NO 20034778D0
Authority
NO
Norway
Prior art keywords
oral
pharmaceutical compositions
topical use
topical
pharmaceutical
Prior art date
Application number
NO20034778A
Other languages
English (en)
Other versions
NO20034778L (no
Inventor
Tomas Andrysek
Milan Stuchlik
Alcs Vrana
Alexandr Jegorov
Josef Stuchlik
Vladimir Matha
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034778(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20034778L publication Critical patent/NO20034778L/no
Application filed by Galena As filed Critical Galena As
Publication of NO20034778D0 publication Critical patent/NO20034778D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
NO20034778A 1999-08-17 2003-10-24 Farmasöytiske sammensetninger for oral og topisk anvendelse NO20034778D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
NO20034778L NO20034778L (no) 2002-04-16
NO20034778D0 true NO20034778D0 (no) 2003-10-24

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020760A NO20020760L (no) 1999-08-17 2002-02-15 Farmasöytiske sammensetninger for oral og topisk administrasjon
NO20034778A NO20034778D0 (no) 1999-08-17 2003-10-24 Farmasöytiske sammensetninger for oral og topisk anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20020760A NO20020760L (no) 1999-08-17 2002-02-15 Farmasöytiske sammensetninger for oral og topisk administrasjon

Country Status (40)

Country Link
US (1) US20070190132A1 (no)
EP (2) EP1210119B1 (no)
JP (2) JP2003507343A (no)
KR (2) KR100828748B1 (no)
CN (2) CN101406453A (no)
AR (2) AR025324A1 (no)
AT (2) ATE288766T1 (no)
AU (1) AU777740B2 (no)
BR (1) BR0013385A (no)
CA (2) CA2452118A1 (no)
CO (1) CO5380014A1 (no)
CY (1) CY1105318T1 (no)
CZ (2) CZ296170B6 (no)
DE (2) DE60018081T2 (no)
DK (2) DK1334717T3 (no)
EE (2) EE04954B1 (no)
EG (1) EG23994A (no)
ES (2) ES2311077T3 (no)
GB (1) GB2355656B (no)
HK (1) HK1049629A1 (no)
HR (1) HRP20020154B1 (no)
HU (1) HUP0203236A3 (no)
IL (4) IL148200A0 (no)
JO (1) JO2324B1 (no)
MX (1) MXPA02001631A (no)
NO (2) NO20020760L (no)
NZ (1) NZ517271A (no)
PE (1) PE20010636A1 (no)
PL (1) PL192769B1 (no)
PT (2) PT1210119E (no)
RU (2) RU2279894C2 (no)
SA (1) SA00210487B1 (no)
SG (1) SG143019A1 (no)
SI (1) SI1210119T1 (no)
SK (2) SK286083B6 (no)
TN (1) TNSN00173A1 (no)
UA (2) UA72539C2 (no)
UY (1) UY26303A1 (no)
WO (1) WO2001012229A1 (no)
ZA (2) ZA200308221B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
WO2004050072A1 (ja) * 2002-12-04 2004-06-17 Nisshin Pharma Inc. コエンザイムｑ１０を含有する水溶性組成物
EP2359859A1 (en) * 2002-12-09 2011-08-24 Abraxis BioScience, LLC Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
MX2007010394A (es) * 2005-02-24 2008-02-19 Elan Pharma Int Ltd Formulaciones nanoparticuladas de docetaxel y analogos del mismo.
CN102227211A (zh) * 2008-11-28 2011-10-26 先进控股有限公司 包含双氯芬酸和羟基脂肪酸聚氧化烯烃酯的药物配制剂
PL2405892T3 (pl) * 2009-03-12 2013-10-31 Lectio Pharmaentwicklungs Und Verwertungs Gmbh Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
WO2016160412A1 (en) * 2015-03-27 2016-10-06 Arch Personal Care Products, Lp Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
TW202406566A (zh) * 2022-05-02 2024-02-16 日商中外製藥股份有限公司 包含用於與界面活性劑結合使用之胜肽化合物的組合物
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
SI0969856T1 (en) * 1997-03-12 2005-06-30 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
CA2294031E (en) * 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
SI1210119T1 (en) 2005-06-30
GB2355656A (en) 2001-05-02
US20070190132A1 (en) 2007-08-16
DE60322454D1 (de) 2008-09-11
PT1334717E (pt) 2008-10-09
EP1210119A1 (en) 2002-06-05
ZA200308221B (en) 2004-09-29
AR025324A1 (es) 2002-11-20
IL158108A0 (en) 2004-03-28
SK286083B6 (sk) 2008-03-05
TNSN00173A1 (en) 2005-11-10
HRP20020154B1 (en) 2006-07-31
CZ296170B6 (cs) 2006-01-11
ATE288766T1 (de) 2005-02-15
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
KR20020059367A (ko) 2002-07-12
CA2380951C (en) 2010-03-23
CN101406453A (zh) 2009-04-15
EE200300371A (et) 2003-10-15
GB9919288D0 (en) 1999-10-20
ATE402691T1 (de) 2008-08-15
WO2001012229A1 (en) 2001-02-22
DE60018081D1 (de) 2005-03-17
ES2311077T3 (es) 2009-02-01
ES2237443T3 (es) 2005-08-01
PL192769B1 (pl) 2006-12-29
UY26303A1 (es) 2001-03-16
AR043106A2 (es) 2005-07-20
GB2355656B (en) 2004-04-07
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
CY1105318T1 (el) 2010-03-03
NO20020760D0 (no) 2002-02-15
UA75926C2 (en) 2006-06-15
HUP0203236A3 (en) 2004-06-28
EE04954B1 (et) 2008-02-15
DK1210119T3 (da) 2005-06-20
PE20010636A1 (es) 2001-06-02
JP2003507343A (ja) 2003-02-25
JO2324B1 (en) 2005-09-12
EG23994A (en) 2008-03-10
RU2279895C2 (ru) 2006-07-20
EP1334717A3 (en) 2004-01-02
PT1210119E (pt) 2005-05-31
BR0013385A (pt) 2002-05-07
NO20020760L (no) 2002-04-16
CA2452118A1 (en) 2001-02-22
EP1210119B1 (en) 2005-02-09
IL158108A (en) 2010-04-15
IL148200A0 (en) 2002-09-12
RU2003133451A (ru) 2005-04-20
AU6461300A (en) 2001-03-13
HK1049629A1 (zh) 2003-05-23
DE60018081T2 (de) 2006-01-05
SA00210487B1 (ar) 2006-09-10
CA2380951A1 (en) 2001-02-22
HRP20020154A2 (en) 2003-12-31
DK1334717T3 (da) 2008-11-24
SG143019A1 (en) 2008-06-27
EP1334717B1 (en) 2008-07-30
IL148200A (en) 2007-12-03
NZ517271A (en) 2004-02-27
CN1382061A (zh) 2002-11-27
UA72539C2 (en) 2005-03-15
HUP0203236A2 (hu) 2003-01-28
PL353445A1 (en) 2003-11-17
RU2279894C2 (ru) 2006-07-20
AU777740B2 (en) 2004-10-28
MXPA02001631A (es) 2003-07-14
JP2004238399A (ja) 2004-08-26
ZA200201315B (en) 2004-06-30
KR100828748B1 (ko) 2008-05-09
CO5380014A1 (es) 2004-03-31
KR20050095651A (ko) 2005-09-29
EP1334717A2 (en) 2003-08-13
EE04955B1 (et) 2008-02-15
SK2482002A3 (en) 2002-12-03
CZ2002575A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
NO20015175L (no) Farmasöytisk sammensetning
FI991485L (fi) Uusi farmaseuttinen koostumus
NO992339D0 (no) Farmas°ytiske formuleringer
PT1242087E (pt) Composicoes farmaceuticas
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DK1095932T3 (da) Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
ITMI991402A0 (it) Composti amorfi e relative composizioni farmaceutiche
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
IS2841B (is) Samstæða hluta og lyfjasamsetningar
PT1239832E (pt) Composicoes farmaceuticas
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
AR025867A1 (es) Formulacion portasdora farmaceutica
SE9904414D0 (sv) Pharmaceutical composition and use
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
SE9803771D0 (sv) Pharmaceutical composition and use
DK1272499T3 (da) Farmaceutiske præparater indeholdende oligosaccharider og fremstilling heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application